Angiotensin II is an essential contributor to the pathogenesis of the glomerular disease, and it is well known that ACE inhibition and angiotensin type 1 receptor (AT1R) block have antiproteinuric effects [73,74]. The gene discussed is AGT; the disease is glomerular disorder.